169 related articles for article (PubMed ID: 15647774)
1. Evaluation of toxicity from high-dose systemic administration of recombinant adenovirus vector in vector-naive and pre-immunized mice.
Varnavski AN; Calcedo R; Bove M; Gao G; Wilson JM
Gene Ther; 2005 Mar; 12(5):427-36. PubMed ID: 15647774
[TBL] [Abstract][Full Text] [Related]
2. Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination.
Bramson JL; Hitt M; Gauldie J; Graham FL
Gene Ther; 1997 Oct; 4(10):1069-76. PubMed ID: 9415313
[TBL] [Abstract][Full Text] [Related]
3. Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice.
Fields PA; Armstrong E; Hagstrom JN; Arruda VR; Murphy ML; Farrell JP; High KA; Herzog RW
Gene Ther; 2001 Mar; 8(5):354-61. PubMed ID: 11313811
[TBL] [Abstract][Full Text] [Related]
4. Host responses and persistence of vector genome following intrabronchial administration of an E1(-)E3(-) adenovirus gene transfer vector to normal individuals.
Harvey BG; Hackett NR; Ely S; Crystal RG
Mol Ther; 2001 Feb; 3(2):206-15. PubMed ID: 11237677
[TBL] [Abstract][Full Text] [Related]
5. Multiple innate inflammatory responses induced after systemic adenovirus vector delivery depend on a functional complement system.
Kiang A; Hartman ZC; Everett RS; Serra D; Jiang H; Frank MM; Amalfitano A
Mol Ther; 2006 Oct; 14(4):588-98. PubMed ID: 16733096
[TBL] [Abstract][Full Text] [Related]
6. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.
Roberts DM; Nanda A; Havenga MJ; Abbink P; Lynch DM; Ewald BA; Liu J; Thorner AR; Swanson PE; Gorgone DA; Lifton MA; Lemckert AA; Holterman L; Chen B; Dilraj A; Carville A; Mansfield KG; Goudsmit J; Barouch DH
Nature; 2006 May; 441(7090):239-43. PubMed ID: 16625206
[TBL] [Abstract][Full Text] [Related]
7. Immune responses to gene therapy vectors: influence on vector function and effector mechanisms.
Bessis N; GarciaCozar FJ; Boissier MC
Gene Ther; 2004 Oct; 11 Suppl 1():S10-7. PubMed ID: 15454952
[TBL] [Abstract][Full Text] [Related]
8. Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors.
Schnell MA; Zhang Y; Tazelaar J; Gao GP; Yu QC; Qian R; Chen SJ; Varnavski AN; LeClair C; Raper SE; Wilson JM
Mol Ther; 2001 May; 3(5 Pt 1):708-22. PubMed ID: 11356076
[TBL] [Abstract][Full Text] [Related]
9. Engineered adenovirus serotypes for overcoming anti-vector immunity.
Dharmapuri S; Peruzzi D; Aurisicchio L
Expert Opin Biol Ther; 2009 Oct; 9(10):1279-87. PubMed ID: 19645630
[TBL] [Abstract][Full Text] [Related]
10. Wild-type adenoviruses from groups A-F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent.
Appledorn DM; Kiang A; McBride A; Jiang H; Seregin S; Scott JM; Stringer R; Kousa Y; Hoban M; Frank MM; Amalfitano A
Gene Ther; 2008 Jun; 15(12):885-901. PubMed ID: 18288208
[TBL] [Abstract][Full Text] [Related]
11. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
[TBL] [Abstract][Full Text] [Related]
12. Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo.
Muruve DA; Cotter MJ; Zaiss AK; White LR; Liu Q; Chan T; Clark SA; Ross PJ; Meulenbroek RA; Maelandsmo GM; Parks RJ
J Virol; 2004 Jun; 78(11):5966-72. PubMed ID: 15140994
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of the inflammatory response to adenovirus vectors.
Liu Q; Muruve DA
Gene Ther; 2003 Jun; 10(11):935-40. PubMed ID: 12756413
[TBL] [Abstract][Full Text] [Related]
14. Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial.
Atencio IA; Grace M; Bordens R; Fritz M; Horowitz JA; Hutchins B; Indelicato S; Jacobs S; Kolz K; Maneval D; Musco ML; Shinoda J; Venook A; Wen S; Warren R
Cancer Gene Ther; 2006 Feb; 13(2):169-81. PubMed ID: 16082381
[TBL] [Abstract][Full Text] [Related]
15. An investigation of adverse effects caused by the injection of high-dose TNFalpha-expressing adenovirus vector into established murine melanoma.
Okada Y; Okada N; Mizuguchi H; Hayakawa T; Mayumi T; Mizuno N
Gene Ther; 2003 Apr; 10(8):700-5. PubMed ID: 12692598
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy.
Sterman DH; Recio A; Vachani A; Sun J; Cheung L; DeLong P; Amin KM; Litzky LA; Wilson JM; Kaiser LR; Albelda SM
Clin Cancer Res; 2005 Oct; 11(20):7444-53. PubMed ID: 16243818
[TBL] [Abstract][Full Text] [Related]
17. Suppressive effects of sugar-modified cationic liposome/NF-kappaB decoy complexes on adenovirus vector-induced innate immune responses.
Huang H; Sakurai F; Higuchi Y; Kawakami S; Hashida M; Kawabata K; Mizuguchi H
J Control Release; 2009 Jan; 133(2):139-45. PubMed ID: 18977256
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of costimulation allows for repeated systemic administration of adenoviral vector in rhesus monkeys.
Haegel-Kronenberger H; Haanstra K; Ziller-Remy C; Ortiz Buijsse AP; Vermeiren J; Stoeckel F; Van Gool SW; Ceuppens JL; Mehtali M; De Boer M; Jonker M; Boon L
Gene Ther; 2004 Feb; 11(3):241-52. PubMed ID: 14737083
[TBL] [Abstract][Full Text] [Related]
19. Use of multiply deleted adenovirus vectors to probe adenovirus vector performance and toxicities.
Amalfitano A
Curr Opin Mol Ther; 2003 Aug; 5(4):362-6. PubMed ID: 14513678
[TBL] [Abstract][Full Text] [Related]
20. Innate immune response induced by gene delivery vectors.
Sakurai H; Kawabata K; Sakurai F; Nakagawa S; Mizuguchi H
Int J Pharm; 2008 Apr; 354(1-2):9-15. PubMed ID: 17640834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
